Folic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model

Context: The cardiotoxic effect of selective cyclo-oxygenase-2 inhibitors is well known. While rofecoxib and valdecoxib have been withdrawn, celecoxib remains on the market. Folic acid, a naturally occurring vitamin, has been shown to reduce myocardial ischemia and post-reperfusion injury in rats. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, Shafique, Panda, Bibhu Prasad, Kohli, Kanchan, Fahim, Mohammad, Dubey, Kiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130581/
https://www.ncbi.nlm.nih.gov/pubmed/28274156
http://dx.doi.org/10.1080/13880209.2017.1299768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130581/
https://www.ncbi.nlm.nih.gov/pubmed/28274156
http://dx.doi.org/10.1080/13880209.2017.1299768

Ejemplares similares